Budapest, Hungary

Katalin Baloghne Nemes

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katalin Baloghne Nemes. Retrieved from https://idiyas.com/inventor/katalin-baloghne-nemes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katalin Baloghne Nemes: Innovator in Anxiolytic Agents

Introduction

Katalin Baloghne Nemes is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anxiolytic agents. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to improving mental health treatments.

Latest Patents

Katalin holds a patent for "1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents." This patent represents her commitment to advancing therapeutic options for anxiety disorders. The innovative compounds she has developed are designed to provide effective relief for individuals suffering from anxiety.

Career Highlights

Katalin is associated with Egis Gyógyszergyár Rt., a leading pharmaceutical company in Hungary. Her role at the company has allowed her to collaborate with other talented professionals in the field. With her extensive knowledge and experience, she has become a valuable asset to her team and the industry.

Collaborations

Katalin has worked alongside notable colleagues, including Istvan Gacsalyi and Imre Klebovich. Their collaborative efforts have contributed to the success of various projects and have fostered a productive research environment.

Conclusion

Katalin Baloghne Nemes is a remarkable inventor whose work in anxiolytic agents has the potential to make a significant impact on mental health treatment. Her dedication to innovation and collaboration continues to inspire those in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…